ADRBK1 Antibody (C-term) Blocking peptide

ADRBK1 Antibody (C-term) Blocking peptide

€363.00
In stock
SKU
AC-BP7004a
Catalog Number: AC-BP7004a
Size: 500 µg
Datasheet
Request Information
Background:
Beta-adrenergic receptor kinase (ADRBK1), also known as GRK2, phosphorylates the beta-2-adrenergic receptor and appears to mediate agonist-specific desensitization observed at high agonist concentrations. ADRBK1 is an ubiquitous cytosolic enzyme that specifically phosphorylates the activated form of the beta-adrenergic and related G-protein-coupled receptors. Heart failure is accompanied by severely impaired beta-adrenergic receptor (beta-AR) function. An important mechanism for the rapid desensitization of beta-AR function is agonist-stimulated receptor phosphorylation by the beta-AR kinase (beta-ARK1), an enzyme known to be elevated in failing human heart tissue. Abnormal coupling of beta-adrenergic receptor to G protein is involved in the pathogenesis of the failing heart.

Other Names:
Beta-adrenergic receptor kinase 1, Beta-ARK-1, G-protein coupled receptor kinase 2, ADRBK1, BARK, BARK1, GRK2

Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP7004a was selected from the C-term region of human GRK2 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Gene Name: GRK2 (HGNC:289)

Gene ID: 156
Primary Accession: P25098
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:ADRBK1 Antibody (C-term) Blocking peptide